Single Ascending Doses (SAD) and Multiple Ascending Doses(MAD) Study of IG001119 in Healthy Adult Participants
NCT07618247 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2026-06-03
Summary
The purpose of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IG001119 in Healthy Participants
Conditions
Interventions
- DRUG
-
Tablets for oral administration.
- DRUG
-
IG001119
Tablets for oral administration.
Sponsors & Collaborators
-
Iongen Therapeutics Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-06-04
- Primary Completion
- 2027-04-30
- Completion
- 2027-05-30
Countries
- Australia
Study Locations
More Related Trials
-
Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects
NCT04044339 ·Status: COMPLETED ·Phase: PHASE1
-
SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects
NCT02657122 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Ascending And Multiple Ascending Dose Study of RO5271983 in Healthy Volunteers
NCT01209221 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of DD-S052P in Healthy Volunteers
NCT07347223 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants
NCT07155980 ·Status: WITHDRAWN ·Phase: PHASE1
-
Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects
NCT03392116 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of ARC-520 in Healthy Volunteers
NCT01872065 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate HT-4253 in Healthy Subjects
NCT06537817 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects
NCT05604287 ·Status: TERMINATED ·Phase: PHASE1
-
CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
NCT03335956 ·Status: COMPLETED ·Phase: PHASE1
-
A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105
NCT06432647 ·Status: COMPLETED ·Phase: PHASE1
-
CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
NCT03508635 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects
NCT00684502 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects
NCT07126704 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects
NCT06019065 ·Status: COMPLETED ·Phase: PHASE1
-
Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069
NCT01100047 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)
NCT05055687 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults
NCT06867796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239
NCT04286750 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending Dose Study in Healthy Volunteers
NCT02404922 ·Status: COMPLETED ·Phase: PHASE1
-
A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects
NCT05948774 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants
NCT07433179 ·Status: RECRUITING ·Phase: PHASE1
-
Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers
NCT01116011 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase Ia Study of KMY Tablets in Healthy Subjects
NCT07314541 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics of a Single Ascending Dose of AZD1704
NCT00692042 ·Status: COMPLETED ·Phase: PHASE1